Was Jim Cramer Right About These 12 Stocks?

Page 3 of 12

10. Bristol Myers (NYSE:BMY)

Number of Hedge Fund Investors: 72

Bristol Myers had been left for dead on Wall Street, plagued by years of missed earnings and patent concerns. But at the time the show aired, the company surprised everyone by raising its full-year guidance and delivering a huge earnings beat. Cramer emphasized:

“What happened with Bristol-Meyers is that after years of repeatedly missing earnings estimates, a new CEO came in and now they’re knocking it out of the park”.

He saw the market finally rewarding a well-executed turnaround, saying:

“They can’t just rely endlessly on Eli Lilly,” he warned, highlighting how Bristol needed a fresh drug pipeline to win back investor confidence.

With new leadership in place and strong execution, Cramer liked the stock again.

And he’s been right about that, with the stock being up more than 20% since his comments.

Page 3 of 12